Contrast-enhanced Ultrasound Market Regional Analysis:
North American Market Insights
The North America region contrast-enhanced ultrasound market is set to observe the highest share of 33% during the review period. The market in this region is expected to escalate on account of growing technological development in medical imaging, as CEUS, with its application in cardiovascular imaging, plays a crucial role in assessing myocardial perfusion and detecting cardiac abnormalities.
The region's commitment to innovation in healthcare technology drives the integration of advanced imaging modalities into clinical practice. Also, kidney-related disorders like chronic kidney disease and renal vascular abnormalities are becoming common cases in this region.
APAC Market Insights
The contrast-enhanced ultrasound market in the Asia Pacific region is poised to witness a notable revenue share of 27% by the end of 2035. The need for accurate diagnostic instruments like CEUS is growing as it's a major contributor to morbidity and death in the area.
According to a survey, the frequency of chronic hepatitis B and C infections has increased by 30% across the Asia Pacific area over the last ten years, underscoring the growing prevalence of liver illnesses. The population of the Asia Pacific area is aging quickly, causing a shift in demographics, as a result heart disease is becoming more common as a result of this demographic shift.
